Researchers identify drug target for dengue virus
Advertisement
Washington: Till date no vaccine or drug has yet become available against the Dengue virus.
A flavivirus like the newly prominent Zika virus, Dengue has become a leading cause of serious illness and death in some Asian and Latin American countries.
Investigators from the American Society for Microbiology have data suggesting that a protein in dengue virus that goes by the scientific name, NS4B, would make a promising target for antiviral drug development.
The team found that a metabolite of the common pain reliever, acetaminophen, called AM404, inhibits Dengue virus from replicating. They identified AM404 as a potential antiviral agent by screening the National Institutes of Health Clinical Collection, a library of small molecules that have been used clinically in humans, using a high-throughput screening system.
Corresponding author Ronald van Rij said that the team was able to determine when replication was being inhibited because they used a derivative of dengue virus that expresses luciferase, a molecule that produces bioluminescence, during replication.
He added this system provides an easy and rapid read-out of virus replication and is therefore very useful for screening purposes.
Like Zika virus, Dengue is transmitted by the mosquito, Aedes aegypti. Dengue, called break bone fever, is notable for causing severe bone and muscle pain, headache and pain behind the eyes.
It is also linked with severe vomiting, red spots or patches on the skin, difficulty breathing, and dark, tarry stools, according to the Centers for Disease Control and Prevention.
A flavivirus like the newly prominent Zika virus, Dengue has become a leading cause of serious illness and death in some Asian and Latin American countries.
Investigators from the American Society for Microbiology have data suggesting that a protein in dengue virus that goes by the scientific name, NS4B, would make a promising target for antiviral drug development.
The team found that a metabolite of the common pain reliever, acetaminophen, called AM404, inhibits Dengue virus from replicating. They identified AM404 as a potential antiviral agent by screening the National Institutes of Health Clinical Collection, a library of small molecules that have been used clinically in humans, using a high-throughput screening system.
Corresponding author Ronald van Rij said that the team was able to determine when replication was being inhibited because they used a derivative of dengue virus that expresses luciferase, a molecule that produces bioluminescence, during replication.
He added this system provides an easy and rapid read-out of virus replication and is therefore very useful for screening purposes.
Like Zika virus, Dengue is transmitted by the mosquito, Aedes aegypti. Dengue, called break bone fever, is notable for causing severe bone and muscle pain, headache and pain behind the eyes.
It is also linked with severe vomiting, red spots or patches on the skin, difficulty breathing, and dark, tarry stools, according to the Centers for Disease Control and Prevention.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.